Regarding the sensitivity and specificity analyses of these markers for prognostic prediction, tissue expression of SIK3 showed better specificity than tissue and serum expression of CA125 (80.0%, 56%, and 50%, respectively) by IHC in ovarian cancer patients. Here, SIK3 is linked to ovarian carcinoma.